Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 9NIH 7INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other neoplasm 1Breast 1

Conditions

Secondary Malignant Neoplasm of Bone 1Breast Neoplasms 1

Interventions

pembrolizumab 1033Carboplatin 971Paclitaxel 942Gemcitabine 799Cisplatin 757Docetaxel 698Bevacizumab 637Nivolumab 520Pemetrexed 507Capecitabine 475Cyclophosphamide 473Fluorouracil 425Dexamethasone 410Rituximab 391Oxaliplatin 352Injections 347Trastuzumab 314atezolizumab 312Cetuximab 291Leucovorin 290Irinotecan 271130-nm albumin-bound paclitaxel 257Prednisone 251Ipilimumab 244Doxorubicin 241Lenalidomide 231Fulvestrant 226fludarabine 219durvalumab 211Erlotinib Hydrochloride 196

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × High-Intensity Focused Ultrasound Ablation × Clear all
NCT00008437 2012-07-02

MRI-Guided Ultrasound Energy in Treating Patients With Stage I, Stage II, or Stage IIIA Breast Cancer

InSightec

Phase 2 Completed
Breast

Breast Neoplasms

NCT01117246 2012-02-20

Pilot Study for Palliation of Pain in Bone Metastases by MR-HIFU

Philips Healthcare

Phase 1/2 Completed
2 enrolled
Other neoplasm

Secondary Malignant Neoplasm of Bone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡